Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

neurodegenerative diseases

This page shows the latest neurodegenerative diseases news and features for those working in and with pharma, biotech and healthcare.

Eisai and Washington University to develop neurodegenerative disease therapies

Eisai and Washington University to develop neurodegenerative disease therapies

The collaboration combines Washington University’s expertise in research focused on neurodegenerative diseases with the Japan-based pharma’s experience in drug discovery and development. ... Commenting on the latest collaboration between the two

Latest news

More from news
Approximately 5 fully matching, plus 78 partially matching documents found.

Latest Intelligence

  • Piloting a route to the biosimilars opportunities in Europe Piloting a route to the biosimilars opportunities in Europe

    Biological medicines represent a major advance in the treatment of serious pathological conditions such as cancer, neurodegenerative and autoimmune diseases, in the form of biosimilars. ... For orphan designations (medicine for rare diseases),

  • Alzheimer’s disease: the search for a cure Alzheimer’s disease: the search for a cure

    Advances in technology are providing huge opportunities to intervene decades earlier, when these diseases first start to take hold. ... That’s where the Early Detection of Neurodegenerative diseases (EDoN) initiative comes in.

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    and a decade as senior director of neurodegenerative diseases research at Merck Serono where he served as its leader for in vitro pharmacology in neurology, including in multiple sclerosis, Parkinson’s ... and Alzheimer’s diseases.

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    big diseases in the field, such as Alzheimer’s, is too limited to make near-term success likely. ... Based on what we felt was the state of the art in terms of understanding the pathogenesis of major diseases, especially neurodegenerative diseases, and

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Biogen appoints executive VP, corporate development Biogen appoints executive VP, corporate development

    to tackle unmet needs in neurological diseases.”. ... I'm excited to work with Biogen's innovative and talented team as we work to expand the company's portfolio of therapies for people living with serious neurodegenerative diseases.”.

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... The Prevail team has

  • Asceneuron appoints chief medical officer Asceneuron appoints chief medical officer

    Novartis’ Michael Ryan joins the neurodegenerative diseases specialist. Lausanne, Switzerland-based Asceneuron has appointed Michael Ryan as its new chief medical officer. ... He joins the neurodegenerative diseases specialist from Novartis, where he

  • UK Dementia Research Institute names director UK Dementia Research Institute names director

    Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and leads its laboratory for the research of neurodegenerative diseases.

  • Merck’s Michel Vounatsos moves to Biogen Merck’s Michel Vounatsos moves to Biogen

    neurodegenerative and rare diseases around the world.

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...

Quick links